PP 3.9 – 00146 Impact of time on antiretroviral therapy on the proviral reservoir in people living with HIV

PP 3.9 – 00146 Impact of time on antiretroviral therapy on the proviral reservoir in people living with HIV

Bibliographic Details
Main Authors:	S. Rutsaert, M. Pardons, T. Struyve, L. Lambrechts, L. Vandekerckhove
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664022001273

Similar Items

OP 3.8 – 00066 Characterization of the HIV-1 viral reservoir in subtype B early treated individuals
by: T. Struyve, et al.
Published: (2022-12-01)

PP 1.23 – 00130 Long-read sequencing assay allows accurate characterization of the HIV-1 reservoir
by: L. Lambrechts, et al.
Published: (2022-12-01)

OP 1.7 – 00194 Potent latency reversal enables in-depth transcriptomic analysis of the translation-competent HIV-1 reservoir
by: M. Pardons, et al.
Published: (2022-12-01)

Intact Proviral DNA Analysis of the Brain Viral Reservoir and Relationship to Neuroinflammation in People with HIV on Suppressive Antiretroviral Therapy
by: Dana Gabuzda, et al.
Published: (2023-04-01)

Intact proviral DNA levels decline in people with HIV on antiretroviral therapy
by: J. Cyktor, et al.
Published: (2019-12-01)

Emerging PCR-Based Techniques to Study HIV-1 Reservoir Persistence
by: Laurens Lambrechts, et al.
Published: (2020-01-01)

Role of Proviral HIV-1 DNA Genotyping for People Living with HIV (PLWH) Who Had Low-Level Viremia While Receiving Antiretroviral Therapy
by: Lv S, et al.
Published: (2023-07-01)

PP 3.3 – 00071 Longitudinal proviral landscape and reservoir dynamics in a unique case of HIV superinfection
by: F. Harrison Omondi, et al.
Published: (2022-12-01)

The Architecture of Circulating Immune Cells Is Dysregulated in People Living With HIV on Long Term Antiretroviral Treatment and Relates With Markers of the HIV-1 Reservoir, Cytomegalovirus, and Microbial Translocation
by: Lisa Van de Wijer, et al.
Published: (2021-04-01)

Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir
by: Marion Pardons, et al.
Published: (2023-12-01)

Safety, tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464, an investigational antiviral drug, in individuals living with HIV-1: a Phase IIa randomised controlled study
by: Sofie Rutsaert, et al.
Published: (2019-01-01)

PP 3.5 – 00110 The proviral quasispecies of HIV-1
by: A. Telesnitsky, et al.
Published: (2022-12-01)

Measuring Proviral HIV-1 DNA: Hurdles and Improvements to an Assay Monitoring Integration Events Utilising Human <i>Alu</i> Repeat Sequences
by: Eva Malatinkova, et al.
Published: (2021-12-01)

PP 1.7 – 00051 Continuous decline of intact proviral DNA after two decades of antiretroviral therapy
by: M. Nühn, et al.
Published: (2022-12-01)

PP 3.17 – 00211 Genetic Diversity of HIV-1 Long Terminal Repeat in Proviral Populations During Long-Term Antiretroviral Therapy
by: T. Nguyen, et al.
Published: (2022-12-01)

Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients.
by: Anni A Winckelmann, et al.
Published: (2013-01-01)

HIV Proviral Burden, Genetic Diversity, and Dynamics in Viremic Controllers Who Subsequently Initiated Suppressive Antiretroviral Therapy
by: F. Harrison Omondi, et al.
Published: (2021-12-01)

Proviral landscape in children parallels adults and enables reservoir reconstruction
by: J. Hasson, et al.
Published: (2019-12-01)

Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy
by: M. Peluso, et al.
Published: (2019-12-01)

HIV-1 Proviral Genome Engineering with CRISPR-Cas9 for Mechanistic Studies
by: Usman Hyder, et al.
Published: (2024-02-01)

HIV proviral genetic diversity, compartmentalization and inferred dynamics in lung and blood during long-term suppressive antiretroviral therapy.
by: Aniqa Shahid, et al.
Published: (2022-11-01)

Interplay between the Lung Microbiome, Pulmonary Immunity and Viral Reservoirs in People Living with HIV under Antiretroviral Therapy
by: Zihui Wang, et al.
Published: (2022-10-01)

Social representations of antiretroviral therapy for people living with HIV
by: Shaiene Naiara Araújo, et al.
Published: (2021-07-01)

Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA
by: Lorenzi, Julio C. C., et al.
Published: (2018)

Damaging the Integrated HIV Proviral DNA with TALENs.
by: Christy L Strong, et al.
Published: (2015-01-01)

Dynamic Shifts in the HIV Proviral Landscape During Long Term Combination Antiretroviral Therapy: Implications for Persistence and Control of HIV Infections
by: Elizabeth M. Anderson, et al.
Published: (2020-01-01)

PP 4.14 – 00173 Antiretroviral therapy repairs CD4 T cell dysregulation in people living with HIV
by: A. Sponaugle, et al.
Published: (2022-12-01)

Proviral Turnover During Untreated HIV Infection Is Dynamic and Variable Between Hosts, Impacting Reservoir Composition on ART
by: Kelsie Brooks, et al.
Published: (2021-08-01)

In-depth single-cell analysis of translation-competent HIV-1 reservoirs identifies cellular sources of plasma viremia
by: Basiel Cole, et al.
Published: (2021-06-01)

A highly multiplexed droplet digital PCR assay to measure the intact HIV-1 proviral reservoir
by: Claire N. Levy, et al.
Published: (2021-04-01)

Mental health of people living with hiv and adherence to antiretroviral therapy
by: F. Goma, et al.
Published: (2021-04-01)

Social Representations of Aids and of the Antiretroviral Therapy for People Living with HIV
by: Tatiana de Lucena Torres, et al.
Published: (2008-01-01)

Effectiveness of four antiretroviral regimens for treating people living with HIV.
by: Aracele Tenório de Almeida E Cavalcanti, et al.
Published: (2020-01-01)

Antiretroviral Side Effects on Adherence in People Living with HIV/AIDS
by: Gede Arya Bagus Arisudhana, et al.
Published: (2018-12-01)

Comparative HIV-1 Proviral Dynamics in Two Individuals That Maintained Viral Replication Control with or without Antiretroviral Therapy following Superinfection
by: Suwellen Sardinha Dias de Azevedo, et al.
Published: (2022-12-01)

Transcriptional Circuit Fragility Influences HIV Proviral Fate
by: Emily L. Morton, et al.
Published: (2019-04-01)

Impact of age, antiretroviral therapy, and cancer on epigenetic aging in people living with HIV
by: Yulan Qing, et al.
Published: (2023-05-01)

HTLV-2 Enhances CD8<sup>+</sup> T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1
by: María Abad-Fernández, et al.
Published: (2022-11-01)

PP 4.24 – 00176 Impact of cannabis use on immune cell populations and the viral reservoir in HIV-infected people on suppressive antiretroviral therapy
by: Shane D. Falcinelli, et al.
Published: (2022-12-01)

The Significance of Taking Antiretroviral Medications for African-Born People Living with HIV and Residing in Minnesota
by: Alina Cernasev, et al.
Published: (2020-06-01)